Anticoagulant Therapies in Particular Clinical Conditions
A special issue of Medicina (ISSN 1648-9144).
Deadline for manuscript submissions: closed (20 November 2021) | Viewed by 2398
Special Issue Editors
2. SHRO, Temple University, Philadelphia, PA 19122, USA
Interests: thrombosis; hemostasis; anticoagulant therapies; hereditary and acquired thrombophilia
Interests: thrombosis; hemostasis; anticoagulant therapies; hereditary and acquired thrombophilia
Interests: women's issues; thrombotic disease; hemorrhagic disease; pregnancy issues; transfusion complications
Special Issue Information
Dear Colleagues,
The daily clinical use of heparins, vitamin K antagonists, and direct oral anticoagulants in the management of difficult clinical situations such as assisted reproductive technologies, antiphospholipid syndrome, SARS-CoV-2 infection, renal failure, venous thrombosis in unusual sites, and isolated distal deep vein thrombosis is often challenging. What is needed is to give helpful suggestions in managing such patients from a practical point of view, even when there are no so clear evidence-based recommendations about treatment.
It is well known that both in- and outpatients often show clinical characteristics and comorbidities that have been excluded from all randomized clinical trials, but despite this, such patients need a final therapeutic decision.
This Special Issue of Medicina on “Anticoagulant Therapies in particular clinical conditions”, showing gray areas of the topics cited above, has the aim to help doctors in their daily clinical practice.
Dr. Doris Barcellona
Prof. Francesco Marongiu
Dr. Elvira Grandone
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- antivitamin-k antagonists
- direct oral anticoagulants
- assisted reproductive technologies
- antiphospholipid syndrome
- SARS-COV 2 and thrombosis
- renal failure
- venous thrombosis in unusual site
- distal deep vein thrombosis
